Therefore, we used a transgenically enhanced Gal-3 expression in β cells to analyze the effect of intracellular Gal-3 in MLD–STZ–induced diabetes in C57Bl/6 mice. The gene discussed is LGALS3; the disease is diabetes mellitus.